Toxicity Associated with Intensive Post-Induction Therapy Incorporating Clofarabine in the Very High Risk Stratum of Patients with Newly Diagnosed High Risk B-Lymphoblastic Leukemia: a Report from the Children’s Oncology Group Study AALL1131

BACKGROUND: Children, adolescents and young adults with very high-risk (VHR) B acute lymphoblastic leukemia (B-ALL) have a poor outcome and novel therapies are needed for this subgroup. AALL1131 evaluated post-Induction therapy for patients with VHR B-ALL using cyclophosphamide (CPM), etoposide (ETO...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Cancer
Autors principals: Salzer, Wanda L., Burke, Michael J., Devidas, Meenakshi, Chen, Si, Gore, Lia, Larsen, Eric C., Borowitz, Michael, Wood, Brent, Heerema, Nyla A., Carroll, Andrew J., Hilden, Joanne M., Loh, Mignon L., Raetz, Elizabeth A., Winick, Naomi J., Carroll, William L., Hunger, Stephen P
Format: Artigo
Idioma:Inglês
Publicat: 2017
Matèries:
Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC5839964/
https://ncbi.nlm.nih.gov/pubmed/29266189
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/cncr.31099
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars